Clinical trial

Effects of Metformin on Hepatic FFA Metabolism

NCT01729156

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-01-01

PhasePHASE4

Study timeline

Study start (unknown)2013-01-01Date precision: month

Registry last updated2019-10-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Dyslipidemiaunresolved

Interventions

MetforminDRUG · verified · RxNorm: metformin

PlaceboDRUG

Sponsors & collaborators

Lars Christian Gormsenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01729156 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.